A systematic review of randomised controlled trials has found that digital health interventions in home-based palliative care deliver clear benefits in some forms but inconsistent or absent benefits in others. The review, published in BMC Palliative Care, synthesised six randomised controlled trials involving 589 patients and 367 caregivers, and concluded that the impact of these technologies depends less on the technology itself than on how it is structured and delivered.
The researchers, following the Cochrane Handbook and PRISMA guidelines, searched databases for trials published between January 2016 and January 2026 that tested digital interventions in home-based palliative care for adults with terminal illnesses. Two researchers independently performed study screening, quality assessment, and data extraction, and the team conducted a narrative synthesis rather than a meta-analysis, reflecting the heterogeneity of the included studies.
The interventions fell into three broad categories: active digital education, telemedicine and video consultations, and passive digital monitoring of quality of life. Active digital education programmes, tested in two trials, showed the most consistent results, significantly improving patients’ health-related quality of life, overall functional status, and individual physical symptoms including pain, fatigue, and nausea.
The picture for telemedicine and video consultations, examined in three trials, was markedly more mixed. One study demonstrated short-term symptom non-inferiority compared with usual care, but two others reported inconsistent or non-significant quality-of-life trajectories. Notably, one trial observed increased pain and anxiety scores at 12 weeks, a finding the authors link in their key points to scheduled, supply-driven once-weekly consultations that may increase symptom burden and anxiety — a possible nocebo effect that they caution remains to be verified in further studies.
Passive monitoring fared least well. A digital quality-of-life monitoring platform tested in one trial did not yield measurable clinical benefits, primarily because clinical utilisation was extremely low. The review’s key points emphasise that systems providing assessment data without behavioural guidance fail to generate clinical benefit when usage rates are minimal, underscoring that data collection alone does not change care.
Evidence on caregivers was thin. Only one trial reported caregiver-specific outcomes: the Canadian QPSS study found no statistically significant effect on caregiver quality of life. Given that 367 caregivers were represented across the six trials, the authors note that direct evidence regarding caregiver-specific endpoints remains very limited, a substantial gap for interventions that often aim to support family caregivers as much as patients.
Healthcare resource utilisation, reported in three trials, also split along delivery-model lines. Flexible telemedicine integrated with clinical care reduced in-person contacts in one study, whereas fixed-frequency teleconsultations in another and passive monitoring in a third did not demonstrate resource-reduction benefits. The review therefore does not support a blanket claim that digital palliative care saves health system resources; the effect appears contingent on how the service is embedded in existing workflows.
The authors’ overarching conclusion is that the impact of digital health interventions in home-based palliative care varies by intervention structure and delivery model. Active digital education shows consistent benefits for patient outcomes, while evidence for telemedicine, caregiver-specific endpoints, and healthcare resource reduction remains limited, mixed, or inconclusive. Their key points frame the central lesson bluntly: effectiveness depends on the presence of proactive education, behavioural activation, and caregiver involvement rather than on the technology itself.
The review’s context is a growing pressure on home-based palliative care. The authors note that aging populations and rising chronic disease burdens are increasing demand, while traditional care is constrained by resource shortages, regional disparities, and low follow-up efficiency — conditions that have driven rapid adoption of digital tools even as their overall effectiveness and optimal models remained unclear. The review is published as open access under BMC Palliative Care’s early-access model, meaning the version is citable with a permanent DOI but subject to further edits before the final Version of Record.
Looking forward, the authors call for practical multi-centre randomised controlled trials with standardized reporting and workflow-integrated designs. With only six trials available across a decade of search coverage, and with findings diverging sharply by intervention type, the review positions digital palliative care as promising but unproven in much of its scope: beneficial when it actively educates and engages patients, inconclusive when it merely schedules consultations or passively collects data.
Subject of Research: Digital health interventions in home-based palliative care evaluated through a systematic review of randomised controlled trials
Article Title: Digital health interventions in home-based palliative care: a systematic review and narrative synthesis of randomised controlled trials
Article References: Xin, Z., Dan, L., Jixuan, H., & Chan, D. (2026). Digital health interventions in home-based palliative care: a systematic review and narrative synthesis of randomised controlled trials. BMC Palliative Care. https://doi.org/10.1186/s12904-026-02386-5
Image Credits: AI Generated
DOI: 10.1186/s12904-026-02386-5
Keywords: palliative care, digital health, telemedicine, systematic review, randomised controlled trials, quality of life, caregivers, home-based care, healthcare utilization, patient symptoms, Digital, health
News Source: Ophelia Keating. (October 29, 2026). Digital Health Tools Show Mixed Benefits in Home-Based Palliative Care Review. Scienmag.
